[1]
Mohamed Abdelhafeez Ahmed et al. 2024. Canagliflozin Possible Roles: A Potential Antifibrotic Agent in Diabetic Idiopathic Pulmonary Fibrosis in comparison with Metformin. Metallurgical and Materials Engineering. 30, 4 (Dec. 2024), 603–615. DOI:https://doi.org/10.63278/10.63278/mme.v31.1.